Alimera Sciences Current ratio
What is the Current ratio of Alimera Sciences?
The Current ratio of Alimera Sciences Inc. is 2.79
What is the definition of Current ratio?
Current ratio is a liquidity ratio that measures whether or not a company has enough resources to meet its short-term obligations.
mrq (most recent quarter)
The current ratio is an indication of a company's liquidity and measures the capability to meet a company's short-term obligations. It compares a firm's current assets to its current liabilities, and is expressed as current assets divided by current liabilities. The ratio is only useful when two companies are compared within industry because inter industry business operations differ substantially. To determine liquidity, the current ratio is not as helpful as the quick ratio, because it includes all those assets that may not be easily liquidated, like prepaid expenses and inventory.
Acceptable current ratios vary from industry to industry. In many cases an investor would consider a high current ratio to be better than a low current ratio, because a high current ratio indicates that the company is more likely to pay the investor back. Large current ratios are not always a good sign for investors. If the company's current ratio is too high it may indicate that the company is not efficiently using its current assets or its short-term financing facilities. If current liabilities exceed current assets the current ratio will be less than 1. A current ratio of less than 1 indicates that the company may have problems meeting its short-term obligations.
Some types of businesses can operate with a current ratio of less than one however. If inventory turns into cash much more rapidly than the accounts payable become due, then the firm's current ratio can comfortably remain less than one. Inventory is valued at the cost of acquiring it and the firm intends to sell the inventory for more than this cost. The sale will therefore generate substantially more cash than the value of inventory on the balance sheet. Low current ratios can also be justified for businesses that can collect cash from customers long before they need to pay their suppliers.
Current ratio of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with current ratio similar to Alimera Sciences
- Eaton Vance Municipal Income Trust has Current ratio of 2.79
- Corby Spirit & Wine has Current ratio of 2.79
- ATENOR SA has Current ratio of 2.79
- Atenor SA has Current ratio of 2.79
- ON Semiconductor has Current ratio of 2.79
- ChannelAdvisor Corp has Current ratio of 2.79
- Alimera Sciences has Current ratio of 2.79
- Akwel has Current ratio of 2.79
- Akwel has Current ratio of 2.79
- WiSA Technologies Inc has Current ratio of 2.79
- Huffington Capital has Current ratio of 2.79
- Monroe Capital Corp has Current ratio of 2.79
- Chengdu Expressway Co has Current ratio of 2.79